The main difference in branded vs. compounded testosterone comes down to FDA approval. Branded testosterone products are FDA-approved for men with hypogonadism caused by a medical condition, not for low testosterone due to aging alone, and they pass full federal review for safety, effectiveness, and manufacturing quality (FDA, 2025). Compounded testosterone is not FDA-approved. Licensed pharmacies prepare it under federal compounding rules to meet needs an approved product cannot, such as an allergy to a specific ingredient (FDA). Current urology guidance leans toward commercially made products when a suitable one exists (Mulhall et al., 2018).

Both forms use the same active hormone, but the finished products are not equivalent. What separates them is oversight and quality control. Marek Health's hormone health services treat this as a medical decision made after lab confirmation, and its men's hormone care follows the same standard: testosterone is prescribed only when a diagnosis supports it.

Branded vs. compounded testosterone describes two ways the same active hormone reaches a patient. Branded products are FDA-approved and made to fixed federal standards. Compounded versions are pharmacy-prepared under federal exemptions and are not FDA-approved. A licensed provider decides which fits a given case after testing.

How branded and compounded testosterone are made

Branded testosterone is produced by pharmaceutical manufacturers held to federal manufacturing standards (FDA, 2025). Compounded testosterone is prepared under sections 503A or 503B of the federal Food, Drug, and Cosmetic Act, which are exemptions from approval, not approvals themselves (FDA).

Two compounding paths exist. Under 503A, a state-licensed pharmacy prepares a patient-specific prescription. Under 503B, an outsourcing facility makes larger batches, follows current good manufacturing practice, and is inspected by the FDA (FDA).

Quality is the practical concern. Urology guidance notes that compounded testosterone can vary in potency and quality, sometimes between samples from the same pharmacy, because individual pharmacies operate without direct FDA approval (Mulhall et al., 2018). That variation is why providers may add monitoring when a compounded preparation is used.

Branded vs. compounded testosterone at a glance

The two differ most on approval, oversight, and formulation flexibility (Mulhall et al., 2018). The table compares the points that drive the decision.

What forms of testosterone are available?

Both come in several delivery forms, and the form often matters more to daily life than the label. Approved commercial products include injections, skin gels, and patches. Compounded preparations can adjust strength, base, or ester for a specific need.

Injectable esters are the most common starting point, and the choice between them affects dosing rhythm more than results. A breakdown of injectable testosterone esters shows how half-life shapes injection frequency. For men deciding between shots and topicals, the trade-offs in cream and injection delivery come down to absorption, steadiness, and the small transfer risk that topicals carry.

Compounded formulations earn their place when an approved product does not fit, for example when a patient reacts to an ingredient in a commercial gel. That is a clinical reason, not a general upgrade. The same active hormone is delivered either way.

How each option is used in treatment

Both aim to correct a diagnosed deficiency and ease its symptoms, not to raise testosterone in healthy men. Reduced libido, fatigue, low mood, and loss of muscle can track with low testosterone, though symptoms alone do not confirm it (Mulhall et al., 2018).

Diagnosis comes first. The American Urological Association bases the diagnosis on a clearly low testosterone level confirmed by repeated morning testing, together with symptoms, rather than a single reading (Mulhall et al., 2018). Understanding how testosterone is measured helps explain why one number rarely tells the whole story.

Compounded testosterone helps in narrow situations, such as an allergy to a commercial ingredient or a base an approved product does not offer. Guidelines still place commercial products first when one will do the job (Mulhall et al., 2018).

Cost, insurance, and access

Insurance coverage often differs. Branded products may be more likely to be covered, though plans may require a specific form or dose. Compounded testosterone is less often covered, which can shift its cost to the patient. Coverage varies by plan, so confirming terms before starting avoids surprises.

Access to either runs through the same gate: a licensed-provider evaluation, lab confirmation, and a prescription where appropriate. Testosterone is a controlled substance, so a prescription is required after evaluation, and telehealth prescribing is allowed where current regulations and state law permit.

What are the risks of testosterone therapy?

Both branded and compounded testosterone share a similar class of risks because they use the same active hormone, though variation in a compounded product's potency can add its own risk. The 2025 FDA label update removed the older boxed warning about cardiovascular outcomes and added a warning about increased blood pressure (FDA, 2025). That change followed the TRAVERSE trial, which studied men with hypogonadism and preexisting or high cardiovascular risk. It found testosterone noninferior to placebo for major adverse cardiac events while reporting a higher incidence of atrial fibrillation and pulmonary embolism in the testosterone group (Lincoff et al., 2023).

Other effects need routine monitoring. Testosterone can increase red blood cell production (erythrocytosis), which providers monitor and manage with dose changes or, if needed, phlebotomy. It can also raise estradiol, and shifts in estradiol and hormone balance can affect mood and other markers. Testosterone can suppress sperm production as well, and that effect varies between men and may not fully reverse, so men who want to preserve fertility should discuss options with a provider before starting.

Lifestyle still counts. Sleep, resistance training, and body composition influence hormone health, and lab-guided support can complement medical care.

How do patients choose between the two?

The choice is a shared decision between patient and provider, weighted toward the option that fits the diagnosis and the body's response. Branded products bring FDA approval and consistent quality. Compounded products bring formulation flexibility for specific needs, at the cost of approval and, sometimes, of batch-to-batch consistency.

A few factors usually decide it: a sensitivity to a commercial ingredient, the delivery form a patient can stick with, insurance coverage, and whether a reputable pharmacy is available for any compounded preparation. Reviewing common patient questions before an appointment can make that conversation sharper.

Branded vs. compounded testosterone is less a contest than a match. The right product is the one a provider can prescribe safely for a specific person, confirmed by labs and adjusted over time. Guidelines point to commercial products first and reserve compounding for the cases that need it (Mulhall et al., 2018).

Disclaimer: This blog post is intended for informational purposes only and should not be considered medical advice. Always consult a healthcare professional before making changes to your health routine.

FAQs

What is the main difference between branded and compounded testosterone? 

Branded testosterone is FDA-approved and made to fixed federal standards for quality and potency. Compounded testosterone is not FDA-approved; pharmacies prepare it under federal exemptions to meet needs an approved product cannot. Both use the same active hormone, but the finished products are not equivalent in oversight or quality.

Is compounded testosterone FDA-approved? 

No. Compounded testosterone is not FDA-approved. It is made under sections 503A or 503B of the federal Food, Drug, and Cosmetic Act, which are exemptions from approval rather than approvals (FDA).

Why do guidelines favor branded over compounded testosterone? 

The American Urological Association recommends commercially manufactured products over compounded testosterone when a suitable one exists, because compounded products can vary in potency and quality and lack direct FDA approval (Mulhall et al., 2018). Compounding is reserved for needs a commercial product cannot meet.

When is compounded testosterone a reasonable choice? 

Compounded testosterone fits narrow situations, such as an allergy to an ingredient in a commercial product or a strength or base that is not commercially available. A licensed provider decides whether a compounded preparation is appropriate after evaluation and lab testing.

Is branded or compounded testosterone safer? 

Both involve a similar class of risks because they use the same active hormone, though compounded products can vary in potency and quality, which is itself a safety consideration. After the TRAVERSE trial in men with hypogonadism and higher cardiovascular risk, the 2025 FDA label update added a blood pressure warning and removed the older cardiovascular boxed warning (FDA, 2025; Lincoff et al., 2023).

What testing is needed before starting either option? 

A diagnosis of low testosterone rests on symptoms plus a clearly low testosterone level confirmed by repeated morning testing, not a single reading (Mulhall et al., 2018). Testosterone is a controlled substance, so a prescription is required after a provider evaluation.

References

• FDA. Class-Wide Labeling Changes for Testosterone Products. 2025.

• FDA. Compounding and the FDA: Questions and Answers.

• J Urol. 2018;200(2):423–432.

• N Engl J Med. 2023;389(2):107–117.